Professor Bosl is working with EMOTIV, a leading EEG and
bioinformatics company, and Quantum Computing Inc., an innovative,
integrated photonics and quantum optics technology company, to
drive groundbreaking innovations in brain health monitoring and
analysis. These innovations will be tested and implemented with
Purple Point Neurodiagnostics, a company advancing global
neurological healthcare through active collaborations with
hospitals and clinics in Africa
and other underserved regions of the world.
SAN
FRANCISCO, Sept. 26, 2024 /PRNewswire-PRWeb/ -- The
University of San Francisco (USF) Data
Institute has announced a pioneering collaboration led by Professor
William Bosl, director of the
Clinical Neuroinformatics and AI Lab (CNAIL). Professor Bosl is
working with EMOTIV, a leading EEG and bioinformatics company, and
Quantum Computing Inc. (QCi), an innovative, integrated photonics
and quantum optics technology company, to drive groundbreaking
innovations in brain health monitoring and analysis. These
innovations will be tested and implemented with Purple Point
Neurodiagnostics (PPND), a company advancing global neurological
healthcare through active collaborations with hospitals and clinics
in Africa and other underserved
regions of the world.
"Our goal is to transform brain healthcare
by enabling preventive care through early screening and
monitoring," said Professor Bosl. "We are especially interested in
putting new technology into underserved regions of the world where
the impact on the health of communities will be especially
great."
"Our goal is to transform brain healthcare by enabling
preventive care through early screening and monitoring," said
Professor Bosl. "Low-cost, portable EEG technology, together with
advanced computational tools, will enable new and earlier
interventions to be developed, resulting in better outcomes. We are
especially interested in putting new technology into underserved
regions of the world where the impact on the health of communities
will be especially great."
Professor Bosl and EMOTIV share a vision of empowering
individuals to monitor their own brain health while accelerating
brain research globally. Their collaboration aims to pursue
clinical neuroinformatics research to discover digital biomarkers
for neurological, psychiatric, and neurodevelopmental disorders,
leading to earlier detection and informing treatment plans. Powered
by portable EEG technology from EMOTIV, this initiative will bring
together neuroinformatics and data science developed by Dr. Bosl
with the USF Data Institute and his collaborators at Harvard Medical School, with the integrated
clinical experience of USF's School of Nursing and Health
Professions to create new approaches to 'Cura Personalis' -
personalized care for the whole person.
A seed gift of $100,000 was made
by EMOTIV to the USF Data Institute Healthcare AI Initiative, which
has enabled the Clinical Neuroinformatics and AI Lab to launch this
collaborative effort. In addition to ongoing neuroinformatics and
AI research, the lab has initiated a clinical site with the USF
School of Nursing and Health Professions to develop clinical
procedures that will be tested locally and in African clinics
associated with PPND.
"At EMOTIV, our mission is to democratize access to
neurotechnology and create a generalized model of the brain that
unlocks new frontiers in brain health and well-being for the
benefit of all," said Tan Le, CEO.
"Our partnership with the USF Clinical Neuroinformatics and AI Lab
advances this vision."
Dr. Bosl is also pursuing novel approaches to EEG analysis using
the pioneering computational and AI methods enabled by QCi devices
to advance the ability to measure brain function even further. The
goal is to discover patterns of brain electrophysiology that cannot
currently be found by other means.
"The collaboration between USF's Clinical Neuroinformatics and
AI Lab, their Data Institute, the School of Nursing and Health
Professions, and their partners at EMOTIV, exemplifies the kind of
transformative work QCi stands behind," stated Dr. William McGann, CEO. "Our EmuCore reservoir
computing device is playing a pivotal role in enabling the
advancement of neuro-AI applications, including early detection of
brain disorders. This partnership reflects our commitment to
bringing cutting-edge quantum and AI technologies into real-world
solutions that can significantly improve the human condition."
The partners in this collaboration are especially mindful of the
needs of underserved and low-income communities. To this end, CNAIL
has formed a partnership with PPND to take this new technology to
low-income regions of the world for clinical testing and
development.
"At Purple Point Neurodiagnostics, we are dedicated to providing
quality, diagnostic neurological testing throughout the world,
especially in low-resource regions where advanced technology is
often not accessible," said Lucien Kilonda, co-founder and CEO of
PPND. "Our partnership with USF and the Data Institute represents
our combined efforts to develop disruptive, advanced, low-cost
neurotechnology for all people, especially those with the greatest
need for care."
As Dr. Neha Bhasin, USF Digital
Health Informatics alumna and Clinical Director of CNAIL noted,
"We're attempting to redefine neuropsychiatric care by pioneering
the use of EEG data. Our goal is to do fundamental research to
discover biomarkers of brain dysfunction in EEG signals, then to
make EEG more accessible and integrate it seamlessly into clinical
practice, enabling earlier and more effective diagnosis and
treatment of neuropsychiatric disorders."
These partnerships seek a significant advancement in brain
health monitoring, combining Professor Bosl's expertise with the
innovative technologies of EMOTIV and QCi and the global reach of
PPND. Together, they aim to deepen our understanding of brain
function, offering new opportunities for research and clinical
application, offering Cura Personalis to the global community.
For more information about this collaboration or to schedule an
interview with Professor Bosl, please contact:
datainstitute@usfca.edu
About the University of San
Francisco
The University of San Francisco is a
private, Jesuit Catholic university that reflects the diversity,
optimism, and opportunities of the city that surrounds it. USF
offers more than 230 undergraduate, graduate, professional, and
certificate programs in the arts and sciences, business, law,
education, and nursing and health professions. At USF, each course
is an intimate learning community in which top professors encourage
students to turn learning into positive action, so the students
graduate equipped to do well in the world — and inspired to change
it for the better. For more information, visit usfca.edu.
About the University of San
Francisco Data Institute
The University of San Francisco Data
Institute is dedicated to advancing research and education in data
science and engineering, fostering innovation, and collaborating
with industry leaders to solve real-world problems. For more
information, visit usfca.edu/data-institute.
About the University of San
Francisco School of Nursing and Health Professions
The School of Nursing and Health Professions advances the mission
of the university by leading in innovative solutions to health
inequities and transforming healthcare using evidence-informed
approaches. For more information, visit usfca.edu/nursing.
About EMOTIV
EMOTIV is a bioinformatics company revolutionizing the
understanding of the human brain through EEG technology. Their
mission is to empower individuals to gain insights into their own
brain health while advancing global brain research. For more
information, visit emotiv.com.
About Quantum Computing Inc. (QCi)
Quantum Computing Inc. (QCi) (Nasdaq: QUBT) is an innovative,
integrated photonics company that provides accessible and
affordable quantum machines to the world today. QCi products are
designed to operate at room temperature and low power at an
affordable cost. The Company's portfolio of core technology and
products offer unique capabilities in the areas of high-performance
computing, artificial intelligence, cybersecurity, as well as
remote sensing applications, and more, including the new EmuCore
reservoir computer. For more information, visit
quantumcomputinginc.com/.
About Purple Point Neurodiagnostics (PPND)
With over 60 years of combined experience, the PPND team is
dedicated to quality patient care, advocacy and education to
improve patient outcomes and enhance the quality of life by
delivering accurate, accessible, and compassionate neurological
diagnostics worldwide. MindLight Academy offers ABRET-accredited
neurodiagnostic training programs, including an online 10-month
didactic and clinical program in Intraoperative Neuromonitoring.
Future offerings in neuroinformatics and biomedical AI will be
developed. For more information, visit purplepointneuro.com/.
Media Contact
Kellie Samson, University of San Francisco, (415) 601-1915,
ksamson@usfca.edu, https://www.usfca.edu/
View original
content:https://www.prweb.com/releases/professor-william-bosl-of-the-university-of-san-francisco-partners-with-emotiv-quantum-computing-inc--purple-point-neurodiagnostics-to-advance-brain-health-monitoring-302260533.html
SOURCE University of San
Francisco